Recommendations for the treatment of multiple sclerosis with disease-modifying drugs during the COVID-19 pandemic

The novel coronavirus 2019 (COVID-19) and the subsequent pandemic present a challenge to neurologists treating patients with multiple sclerosis (MS) worldwide. Many national professional bodies have responded rapidly by issuing guidelines for the COVID-19 pandemic, primarily focused on MS disease-m...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	R. Kizlaitienė, N. Giedraitienė, I. Sereikė, J. Liutkienė, L. Leščinskienė, G. Kaubrys
Format:	Artigo
Sprog:	Inglês
Udgivet:	Vilnius University Press 2020-06-01
Serier:	Neurologijos seminarai
Fag:	COVID-19 pandemic multiple sclerosis disease-modifying therapies
Online adgang:	https://www.journals.vu.lt/neurologijos_seminarai/article/view/27741
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!